Review Article

Meta-Analysis of the Use of 8-OHdG in Saliva as a Marker of Periodontal Disease

Table 2

Qualitative analysis.

Study author/year [reference]Study typen; age (years)VariablesCase criteria (PD)Saliva sampleResults
8-OHdG (ng/ml)
Significant differenceNOS

Takane et al. 2002 [12]CCPD: 78; 21–69
C: 17; 24–64
8-OHdGAt least 2 sites with PP > 4 mmSPD 4.28 ± 0.10
C 1.56 ± 0.10
Yes8/10
Sawamoto et al. 2005 [15]CCPD:29; 36–68
C: 20; 25–65
8-OHdGAt least 2 sites with PP > 4 mmSPD 4.36 ± 0.18
C: 1.48 ± 0.08
Yes8/10
Takane et al. 2005 [13]CCPD: 18; 21–67
C: 17; 24–64
8-OHdGAt least 2 sites with PP > 4 mmSPD 2.35 ± 0.18
C 1.56 ± 0.1
Yes8/10
Totan et al. 2006 [18]CCPD: 25; 25–55
C: 25; 25–55
AST
ALT
ALP
PP > 5 mm, LA > 40%NS8/10
Greabu et al. 2006 [9]CCPD:30; 16–82
C: 6; 16–82
Uric acid
Cortisol
TAC
Not specifiedNS6/10
Badea et al. 2010 [19]CCPD: 85; —
C: 49; —
8-OHdGNot specifiedPD 3.00–7.50
C 1.20–1.85
Yes5/10
Sezer et al. 2012 [14]CCPD: 20; 29–58
G: 20; 29–58
C: 20; 29–55
8-OHdGAt least 4 sites with PP > 5 mmSPD 3.13 ± 0.22
G 1.58 ± 0.13
C 1.56 ± 0.12
Yes
(Not for PD versus G)
9/10
Komatsu et al. 2013 [16]CCPD: 21; 44.7 ± 8.8
C: 26;41.9 ± 6.2
8-OHdGPDT sensor probeNSPD 3.30 ± 1.44
C 2.10 ± 1.41
Yes7/10
Dede et al. 2013 [7]CCPD: 24; 30–55
C: 24; 18–30
8-OHdGAt least 2 sites with PP > 5 mm and LB > 30%NSPD 0.61 ± 0.14
C 0.50 ± 0.15
No8/10
Pendyala et al. 2013 [20]CCPD: 30; 40–65
C: 30; 40–65
TAC2 or more sites with PP > 4 mm or LA > 4 mm with bleedingNS8/10
Miricescu et al. 2014 [8]CCPD: 20
C: 20
51.3 ± 7.4
8-OHdG
MDA
TAC
GPx
At least 6 sites with PP > 4 mm, LB > 30%NSPD 6.78 ± 1.80
C 6.46 ± 0.93
No8/10
Hernández-Monjaraz et al. 2014 [21]CStPD: 23
C: 26
SOD
TBARS
TAC
Not specified5/10
Baňasová et al. 2014 [22]CCPD: 23; 43 ± 7.6
C: 19; 39.1 ± 8.8
TBARSAt least 16 sites with PP > 4 mm in 2 different quadrantsS8/10
Baltacioglu et al. 2014 [23]CCPD: 68; 26–42
C: 30; 26–37
MDA
TOS
OSI
TAOC
Multiple sites with PP > 5 mm, LB > 30% and LA > 5 mm.NS8/10
Trivedi et al. 2014 [24]CCPD: 30; 20–65
C: 30; 20–65
SOD
GR
CAT
MDA
At least 2 sites with PP > 4 mm or LA > 4 mmNS8/10
Almerich-Silla et al. 2015 [6]CCPD: 33; 41–45
G:16; 35–43
C:37; 38–43
8-OHdG
MDA
GPx
SOD
TAOC
At least 4 sites with PP > 5 mm and LA > 2 mmNSPD 5.54 (4.96–6.12);
G 2.33 (1.84–2.82);
C 2.20 (1.88–2.52)
Yes
(Not for G versus C)
9/10
Zamora-Perez et al. 2015 [17]CCPD: 100; 39.03
C: 60; 40.13
8-OHdGAt least 6 sites with PP >6 mm and LA >5 mmNSPD 11.13 ± 1.91
C 5.10 ± 1.44
9/10

N: sample size; CC: case-control; CS: cross-sectional; PD: periodontal disease; G: gingivitis; C: control group; PP: periodontal pocket; LA: loss of attachment; LB: level of bleeding; S: stimulated; NS: not stimulated.